55 completed, 7 terminated, 6 unknown, 5 recruiting. 76 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 76 | Completed 55, Terminated 7, Unknown 6, Recruiting 5, Withdrawn 2, Active not recruiting 1 |
Follow Parathyroid Diseases: new trials by email Literature Review of Parathyroid Diseases trials Research Report on Parathyroid Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment With Indapamide in Patients With Post-Surgical Hypoparathyroidism Indapamide 1.5 MG SR, Placebo - Hypoparathyroidism Post-surgical | Phase 4 | Recruiting | Lars Rejnmark | 24 | 2025-08-01 | 2025-08-11 |
| Bisphosphonate Prior to Parathyroidectomy in Primary Hyperparathyroidism Zoledronic acid 4 mg, Natriumklorid 9 mg/ml, Fresenius Kabi - Primary Hyperparathyroidism | Phase 4 | Recruiting | University of Aarhus | 140 | 2025-03-01 | 2026-10-01 |
| Does Fluorescence With or Without Indocyanine Green Improve Parathyroid Identification and Preservation Indocyanine green, SPY Portable Handheld Imaging - Parathyroid Dysfunction, Adenoma | Phase 4 | Terminated | University of Alabama at Birmingham | 417 | 2024-04-11 | 2026-05-06 |
| Neutrophil Gelatinase-associated Lipocalin VS Vascular Calcification in Maintenance Hemodialysis Patients palicalcitol - Chronic Kidney Disease-Mineral and Bone Disorder | Phase 4 | Unknown | Xiaoyan Jia | 80 | 2023-04-01 | 2024-03-08 |
| PRevEnting FracturEs in REnal Disease - 1 Denosumab 60 mg/ml, Calcium and vitamin D prophylaxis, Monitoring of post-injection calcium and phosphate - Kidney Diseases, Dialysis; Complications | Phase 4 | Active not recruiting | Western University, Canada | 60 | 2022-06-11 | 2025-05-31 |
| Cholecalciferol Supplementation in Restless Leg Syndrome in Patients With Chronic Kidney Disease Vitamin D, Placebo Oral Tablet - Restless Leg Disorder, Renal Disease Bone | Phase 4 | Withdrawn | University of Sao Paulo General Hospital | 2022-03-31 | 2021-09-30 | |
| Ropivacaine Plus Magnesium Sulphate Infiltration Placebo Comparator: N/S 0.9%, Ropivacaine 10%, Ropivacaine 10% plus magnesium sulphate 10mg/kg - Thyroid Diseases, Parathyroid Diseases | Phase 4 | Completed | Aristotle University Of Thessaloniki | 68 | 2022-01-19 | 2024-07-17 |
| Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease Teriparatide, DXA,VFA, X-ray, HR-pQCT, 18-F NAF PET/CT, Bone biopsy - Adynamic Bone Disease, Chronic Kidney Diseases | Phase 4 | Recruiting | Ditte Hansen | 48 | 2021-12-15 | 2024-04-23 |
| Lidocaine And Neuromonitoring in Thyroid Surgery Intravenous lidocaine, Intravenous placebo, Intra-cuff lidocaine - Thyroid Neoplasm, Parathyroid Neoplasms | Phase 4 | Completed | Saint Petersburg State University, Russia | 110 | 2021-01-25 | 2024-03-21 |
| The Effect of Preoperative Oral Dexamethasone Supplementation on the Outcome of Thyroidectomised Patients. Dexamethasone oral tablet 8mg (Dexamethasone Krka tablets(8mg), Warsaw, Poland)., Placebo oral sweetener (Clio tablets, sweetener with a dispenser, Instantina GES, Vienna, Austria)., Preoparative blood laboratory tests - Hypocalcemia, Vitamin D Deficiency | Phase 4 | Unknown | Medical University of Lodz | 100 | 2020-07-01 | 2022-02-08 |
| Efficacy of Calcium Citrate Versus Calcium Carbonate for the Management of Chronic Hypoparathyroidism Calcium Carbonate, Calcium Citrate - Chronic Hypoparathyroidism | Phase 4 | Completed | Campus Bio-Medico University | 26 | 2019-10-15 | 2020-04-03 |
| Diagnostic Accuracy Study of Indocyanine Green for Parathyroid Perfusion Assessment Indocyanine Green - Thyroid Cancer, Thyroid Goiter | Phase 4 | Completed | University Health Network, Toronto | 10 | 2019-08-06 | 2020-03-27 |
| Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity Calcitonin - Primary Hyperparathyroidism, Hypercalcemia | Phase 4 | Recruiting | Joseph Sferra | 37 | 2019-05-29 | 2024-09-19 |
| Osteoporosis in Primary Hyperparathyroidism Denosumab 60 MG/ML Prefilled Syringe [Prolia], Zoledronic Acid - Primary Hyperparathyroidism, Osteoporosis | Phase 4 | Unknown | University Medical Centre Ljubljana | 40 | 2019-05-08 | 2022-11-04 |
| Burosumab in Children and Adolescents With X-linked Hypophosphatemia Burosumab Injection - Rare Diseases, X-linked Hypophosphatemia | Phase 4 | Unknown | Bicetre Hospital | 57 | 2018-03-18 | 2020-06-05 |
| Minimizing Narcotic Analgesics After Endocrine Surgery Acetaminophen 500Mg Cap, Tylenol #3 Oral Tablet, Tramadol - Thyroid Cancer, Thyroid Nodule | Phase 4 | Completed | Minerva A Romero Arenas | 126 | 2018-03-09 | 2021-05-11 |
| Different Effects of Non-calcium Phosphate Binders on Serum Calcium Sevelamer Hydrochloride, Lanthanum Carbonate - Chronic Kidney Disease | Phase 4 | Completed | Medical University of Lodz | 34 | 2018-03-01 | 2021-07-27 |
| A Study to Learn if Recombinant Human Parathyroid Hormone [rhPTH(1-84)] Can Improve Symptoms and Metabolic Control in Adults With Hypoparathyroidism (BALANCE) rhPTH (1-84), Placebo - Hypoparathyroidism | Phase 4 | Completed | Shire | 93 | 2018-01-24 | 2023-06-09 |
| Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis Patients cardiac MRI, echocardiography with strain, Laboratory tests - Secondary Hyperparathyroidism, Chronic Kidney Disease Requiring Chronic Dialysis | Phase 4 | Completed | Rainer Oberbauer | 62 | 2017-10-01 | 2020-06-09 |
| Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT Cinacalcet HCl - Hyperparathyroidism; Secondary, Renal | Phase 4 | Completed | Kyowa Kirin China Pharmaceutical Co., Ltd. | 750 | 2017-04-19 | 2024-04-29 |
Showing 20 of 76. Sign in to see all of them.
Hyperparathyroidism, Secondary (42) · Renal Insufficiency, Chronic (19) · Hyperparathyroidism (12) · Hyperparathyroidism, Primary (10) · Chronic Kidney Disease-Mineral and Bone Disorder (9) · Hypercalcemia (9) · Vitamin D Deficiency (9) · Kidney Failure, Chronic (8) · Hypoparathyroidism (7) · Bone Diseases, Metabolic (5) · Osteoporosis (5) · Renal Insufficiency (4) · Hyperphosphatemia (3) · Hypocalcemia (3) · Kidney Diseases (3)
Endocrine System Diseases (76) · Hyperparathyroidism (52) · Pathological Conditions, Signs and Symptoms (40) · Pathologic Processes (35) · Female Urogenital Diseases (34) · Female Urogenital Diseases and Pregnancy Complications (34) · Male Urogenital Diseases (34) · Urogenital Diseases (34) · Urologic Diseases (34) · Nutritional and Metabolic Diseases (33) · Disease Attributes (32) · Chronic Disease (31) · Kidney Diseases (31) · Metabolic Diseases (30)
paricalcitol (19) · Cinacalcet (18) · 1 alpha-hydroxyergocalciferol (10) · Calcitriol (9) · Vitamin D (6) · Ergocalciferols (4) · Cholecalciferol (3) · Denosumab (3) · Zoledronic Acid (3) · Alendronate (2) · Indocyanine Green (2) · Sevelamer (2) · Acetaminophen (1) · Atorvastatin (1) · Blood Specimen Collection (1)
Amgen (8) · Abbott (7) · Genzyme, a Sanofi Company (4) · Columbia University (3) · Medical University of Lodz (2) · Papageorgiou General Hospital (2) · Shire (2) · The University of Hong Kong (2) · University of Sao Paulo General Hospital (2) · AbbVie (prior sponsor, Abbott) (1) · Aristotle University Of Thessaloniki (1) · Bicetre Hospital (1) · Campus Bio-Medico University (1) · Chinese University of Hong Kong (1) · Chulalongkorn University (1)
United States (26) · Denmark (6) · Italy (5) · Spain (4) · Brazil (3) · Canada (3) · China (3) · France (3) · Greece (3) · Hong Kong (3) · Austria (2) · Germany (2) · Israel (2) · Netherlands (2) · Poland (2)
Efstathios Mitsopoulos, MD (2) · Aihua Zhang (1) · Aili Jiang (1) · Anat Tsur, MD (1) · Angela YM Wang, MD PhD (1) · Angela YM Wang, MD, PhD (1) · Anna Grzegory, MD (1) · Anne F Cailleux, MD (1) · Bruno Niederle, Prof., MD (1) · Chaosheng Chen (1) · Csaba P. Kovesdy, M.D. (1) · Daniel W Coyne, MD (1)
PMID 17666472, PMID 18178780, PMID 18423809, PMID 19018785, PMID 19365139, PMID 19470620, PMID 20943783, PMID 22387567, PMID 22863242, PMID 23705925, PMID 24214232, PMID 24500308, PMID 24589316, PMID 24970869, PMID 25645432, PMID 25781618, PMID 25873267, PMID 31014177, PMID 31310310, PMID 31651370, PMID 32738041, PMID 33825489, PMID 34754193, PMID 35559350, PMID 35872799, PMID 35974422, PMID 36018496, PMID 36869794, PMID 37729887, PMID 37932788, PMID 38040277, PMID 40576086, PMID 40711996, PMID 40935429, PMID 41847596
2008 (2), 2009 (1), 2017 (1), 2018 (1), 2023 (1), R01DK032333 (1), R01DK084986 (1)